PE20030100A1 - Compuestos de n-formil-hidroxilamina - Google Patents
Compuestos de n-formil-hidroxilaminaInfo
- Publication number
- PE20030100A1 PE20030100A1 PE2002000516A PE2002000516A PE20030100A1 PE 20030100 A1 PE20030100 A1 PE 20030100A1 PE 2002000516 A PE2002000516 A PE 2002000516A PE 2002000516 A PE2002000516 A PE 2002000516A PE 20030100 A1 PE20030100 A1 PE 20030100A1
- Authority
- PE
- Peru
- Prior art keywords
- formil
- compounds
- hexanoyl
- pyrrolidin
- hydroxy
- Prior art date
Links
- 239000002253 acid Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- -1 FORMYL-HYDROXY-AMINO Chemical class 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE A COMPUESTOS DE N-FORMIL-HIDROXILAMINA DE FORMULA I DONDE X ES -CH2-, -S-, -CH(OH)-, -CH(OR)-, -CF2-, ENTRE OTROS; R1 ES ARILO, HETEROARILO; R2-R5 SON H, ALQUILO O JUNTOS FORMAN UN CICLOALQUILO DE 4-7 ATOMOS; n ES 0-3. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. SON COMPUESTOS PREFERIDOS PIRIDIN-2-ILAMINA DEL ACIDO 1-{2-R-[(FORMIL-HIDROXI-AMINO)-METIL]-HEXANOIL}-PIRROLIDIN-2-S-CARBOXILICO, (3-METIL-PIRIDIN-2-IL)-AMIDA DEL ACIDO 1-{2-R-[(FORMIL-HIDROXI-AMINO)-METIL]-HEXANOIL}-PIRROLIDIN-2-S-CARBOXILICO ENTRE OTROS. LOS COMPUESTOS MENCIONADOS SON INHIBIDORES DE LA ENZIMA PEPTIDO-DESFORMILASA (PDF) Y SON UTILES COMO AGENTES BACTERIANOS
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29841901P | 2001-06-15 | 2001-06-15 | |
| US36031302P | 2002-02-27 | 2002-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030100A1 true PE20030100A1 (es) | 2003-03-28 |
Family
ID=26970649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000516A PE20030100A1 (es) | 2001-06-15 | 2002-06-14 | Compuestos de n-formil-hidroxilamina |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7148242B2 (es) |
| EP (1) | EP1401828B1 (es) |
| JP (1) | JP4361365B2 (es) |
| KR (2) | KR100589544B1 (es) |
| CN (1) | CN1511152A (es) |
| AR (1) | AR036053A1 (es) |
| AT (1) | ATE323081T1 (es) |
| AU (1) | AU2002321062B2 (es) |
| BR (1) | BR0210377A (es) |
| CA (1) | CA2448526A1 (es) |
| CO (1) | CO5640131A2 (es) |
| CY (1) | CY1105085T1 (es) |
| CZ (1) | CZ20033388A3 (es) |
| DE (1) | DE60210612T2 (es) |
| DK (1) | DK1401828T3 (es) |
| ES (1) | ES2262824T3 (es) |
| HU (1) | HUP0400208A3 (es) |
| IL (1) | IL158770A0 (es) |
| MX (1) | MXPA03011628A (es) |
| MY (1) | MY138619A (es) |
| NO (1) | NO327420B1 (es) |
| NZ (1) | NZ529489A (es) |
| PE (1) | PE20030100A1 (es) |
| PL (1) | PL364476A1 (es) |
| PT (1) | PT1401828E (es) |
| RU (1) | RU2325386C2 (es) |
| SI (1) | SI1401828T1 (es) |
| SK (1) | SK15242003A3 (es) |
| WO (1) | WO2002102790A1 (es) |
| ZA (1) | ZA200308379B (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002102791A1 (en) * | 2001-06-15 | 2002-12-27 | Vicuron Pharmaceuticals Inc. | Pyrrolidine bicyclic compounds |
| GB0208579D0 (en) * | 2002-04-13 | 2002-05-22 | British Biotech Pharm | Antibacterial agents |
| RU2374227C2 (ru) * | 2002-09-19 | 2009-11-27 | Новартис Аг | Способ получения промежуточных соединений |
| WO2004076053A2 (en) * | 2003-02-21 | 2004-09-10 | Novartis Ag | Chemical process for the preparation of intermediates to obtain n-formyl hydroxylamine compounds |
| TW200427458A (en) * | 2003-04-02 | 2004-12-16 | Novartis Ag | Crystalline N-formyl hydroxylamine compounds |
| JP2009513485A (ja) * | 2003-06-26 | 2009-04-02 | ノバルティス アクチエンゲゼルシャフト | ある種の抗菌性ｎ−ホルミルヒドロキシルアミン化合物の製造に有用な中間体の製造法 |
| KR100527624B1 (ko) * | 2003-08-21 | 2005-11-22 | 한기종 | 질소에 포밀기를 갖는 아민유도체의 새로운 제조방법 |
| TW200607492A (en) * | 2004-06-30 | 2006-03-01 | Novartis Ag | Method for increasing the susceptibility of peptide deformylase inhibitors by using efflux pump inhibitors |
| US20080161249A1 (en) * | 2004-11-17 | 2008-07-03 | Smithkline Beecham Corporation | Use of Novel Antibacterial Compounds |
| GT200600196A (es) * | 2005-05-23 | 2007-01-15 | Compuestos n-formil de hidroxilamina | |
| DE102005026231A1 (de) * | 2005-06-07 | 2006-12-14 | Origenis Ag | Peptid-Deformylase (PDF) Inhibitoren 3 |
| BRPI0611694A2 (pt) * | 2005-06-07 | 2010-09-28 | Novartis Ag | inibidores peptìdicos da deformilase 4 (pdf) |
| SG133452A1 (en) * | 2005-12-30 | 2007-07-30 | Novartis Ag | Peptide deformylase inhibitors for treatment of mycobacterial and other parasitic diseases |
| CN101395148A (zh) * | 2006-03-03 | 2009-03-25 | 诺瓦提斯公司 | N-甲酰基羟胺化合物 |
| CN101328155B (zh) * | 2007-06-20 | 2010-11-03 | 上海医药工业研究院 | 噁唑烷衍生物及其制备方法和应用 |
| CN101434570B (zh) * | 2007-11-16 | 2011-02-02 | 上海医药工业研究院 | 吡咯烷衍生物及其制备方法和应用 |
| CN101584694B (zh) * | 2009-06-15 | 2011-01-12 | 华东师范大学 | 含2,5-二氢吡咯的肽脱甲酰基酶抑制剂及合成方法 |
| MX2012002752A (es) * | 2009-09-04 | 2012-04-19 | Novartis Ag | Compuestos de heteroarilo como inhibidores de cinasa. |
| US8518948B2 (en) * | 2010-03-10 | 2013-08-27 | Ingenium Pharmaceuticals Gmbh | Inhibitors of protein kinases |
| JP5825086B2 (ja) | 2011-12-19 | 2015-12-02 | 住友化学株式会社 | α−置換−β−アミノ酸エステル誘導体不斉加水分解酵素 |
| US9512084B2 (en) | 2013-11-29 | 2016-12-06 | Novartis Ag | Amino pyrimidine derivatives |
| WO2016164580A1 (en) | 2015-04-07 | 2016-10-13 | Novartis Ag | Combination of chimeric antigen receptor therapy and amino pyrimidine derivatives |
| EP3483155B1 (en) * | 2016-05-11 | 2022-10-26 | Guangdong Hebo Pharmaceutical Co., Ltd. | Spiro three-membered ring or spiro five-membered ring peptide deformylase inhibitor and use thereof as an anti-tumour agent |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3215705A (en) * | 1963-10-11 | 1965-11-02 | American Cyanamid Co | 4-amino-3-hydroxymethyl indole derivatives |
| US4052511A (en) * | 1976-02-13 | 1977-10-04 | E. R. Squibb & Sons, Inc. | Carboxyacylproline derivatives |
| US4311705A (en) * | 1980-10-06 | 1982-01-19 | E. R. Squibb & Sons, Inc. | Carboxyalkanoyl and hydroxycarbamoylalkanoyl derivatives of substituted prolines |
| US4321383A (en) * | 1980-11-24 | 1982-03-23 | E. R. Squibb & Sons, Inc. | Heterobicyclo intermediates |
| US4303662A (en) * | 1980-11-24 | 1981-12-01 | E. R. Squibb & Sons, Inc. | Carboxyacyl, mercapto and acylmercapto derivatives of heterobicyclo compounds |
| JPS6188884A (ja) * | 1984-10-04 | 1986-05-07 | Sankyo Co Ltd | エンケフアリナ−ゼｂ阻害物質およびその製法 |
| AU580855B2 (en) * | 1985-03-29 | 1989-02-02 | Shionogi & Co., Ltd. | Alkeneamidocephalosporin esters |
| US4599361A (en) * | 1985-09-10 | 1986-07-08 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
| DK77487A (da) | 1986-03-11 | 1987-09-12 | Hoffmann La Roche | Hydroxylaminderivater |
| FR2609289B1 (fr) | 1987-01-06 | 1991-03-29 | Bellon Labor Sa Roger | Nouveaux composes a activite d'inhibiteurs de collagenase, procede pour les preparer et compositions pharmaceutiques contenant ces composes |
| US5128346A (en) * | 1987-09-21 | 1992-07-07 | Abbott Laboratories | Derivatives of D-glutamic acid and D-aspartic acid |
| EP0334244A3 (en) | 1988-03-25 | 1991-05-29 | The Procter & Gamble Company | Bradykinin antagonist peptides |
| GB8827305D0 (en) | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
| GB8827308D0 (en) | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
| GB8919251D0 (en) | 1989-08-24 | 1989-10-04 | British Bio Technology | Compounds |
| GB8921326D0 (en) | 1989-09-21 | 1989-11-08 | Beecham Group Plc | Novel treatment |
| US5268384A (en) * | 1990-11-21 | 1993-12-07 | Galardy Richard E | Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
| DE69108529T2 (de) | 1990-12-03 | 1995-11-30 | Celltech Therapeutics Ltd | Peptidylderivate. |
| CA2058797A1 (en) | 1991-02-01 | 1992-08-02 | Michael John Broadhurst | Amino acid derivatives |
| GB9102635D0 (en) | 1991-02-07 | 1991-03-27 | British Bio Technology | Compounds |
| IT1245712B (it) * | 1991-04-09 | 1994-10-14 | Boehringer Mannheim Italia | Ammine eterocicliche utili terapia dell'asma e dell'infiammazione delle vie aeree |
| WO1992022523A2 (en) | 1991-06-14 | 1992-12-23 | Research Corporation Technologies, Inc. | Peptide derivatives of collagenase inhibitor |
| US5256657A (en) * | 1991-08-19 | 1993-10-26 | Sterling Winthrop, Inc. | Succinamide derivative matrix-metalloprotease inhibitors |
| JPH05125029A (ja) | 1991-11-06 | 1993-05-21 | Yamanouchi Pharmaceut Co Ltd | 新規なアミド化合物又はその塩 |
| CA2123104A1 (en) | 1991-11-08 | 1993-05-13 | Yukio Sugimura | Collagenase inhibitor |
| DE69309047T2 (de) | 1992-04-07 | 1997-09-11 | British Biotech Pharm | Hydroxamsäure enthaltende collagenase-inhibitoren und cytokinaktivitätsinhibitoren |
| GB9211707D0 (en) | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
| GB9211706D0 (en) | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
| US5318964A (en) * | 1992-06-11 | 1994-06-07 | Hoffmann-La Roche Inc. | Hydroxamic derivatives and pharmaceutical compositions |
| GB9215665D0 (en) | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
| US5552419A (en) * | 1993-01-06 | 1996-09-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
| TW290541B (es) | 1993-03-18 | 1996-11-11 | Otsuka Pharma Factory Inc | |
| CA2139128A1 (en) | 1993-04-27 | 1994-11-10 | Celltech Therapeutics Limited | Peptidyl derivatives as metalloproteinase inhibitors |
| GB9308695D0 (en) | 1993-04-27 | 1993-06-09 | Celltech Ltd | Peptidyl derivatives |
| GB9501737D0 (en) | 1994-04-25 | 1995-03-22 | Hoffmann La Roche | Hydroxamic acid derivatives |
| GB9411598D0 (en) | 1994-06-09 | 1994-08-03 | Hoffmann La Roche | Hydroxamic acid derivatives |
| GB9502858D0 (en) | 1995-02-14 | 1995-04-05 | British Biotech Pharm | Novel use of matrix metalloproteinase inhibitors |
| GB9504084D0 (en) | 1995-03-01 | 1995-04-19 | British Biotech Pharm | Synthesis of carboxylic and hydroxamic acid derivatives |
| FR2733750B1 (fr) | 1995-05-03 | 1997-06-13 | Synthelabo | Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique |
| US6204260B1 (en) | 1996-02-23 | 2001-03-20 | Eli Lilly And Company | Non-peptidyl vasopressin V1a antagonists |
| TW448172B (en) | 1996-03-08 | 2001-08-01 | Pharmacia & Upjohn Co Llc | Novel hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation |
| GB9613547D0 (en) | 1996-06-27 | 1996-08-28 | Pharmacia Spa | Matrix metalloproteinase inhibitors |
| AUPO721997A0 (en) | 1997-06-06 | 1997-07-03 | Queensland Institute Of Medical Research, The | Anticancer compounds |
| EP0925289A1 (en) | 1997-07-10 | 1999-06-30 | PHARMACIA & UPJOHN S.p.A. | Matrix metalloproteinase inhibitors |
| US6423690B1 (en) * | 1998-02-07 | 2002-07-23 | British Biotech Pharmaceuticals Ltd. | Antibacterial agents |
-
2002
- 2002-06-13 AR ARP020102229A patent/AR036053A1/es not_active Application Discontinuation
- 2002-06-14 PT PT02754681T patent/PT1401828E/pt unknown
- 2002-06-14 MY MYPI20022243A patent/MY138619A/en unknown
- 2002-06-14 CA CA002448526A patent/CA2448526A1/en not_active Abandoned
- 2002-06-14 CN CNA028105966A patent/CN1511152A/zh active Pending
- 2002-06-14 DE DE60210612T patent/DE60210612T2/de not_active Expired - Lifetime
- 2002-06-14 ES ES02754681T patent/ES2262824T3/es not_active Expired - Lifetime
- 2002-06-14 KR KR1020037016435A patent/KR100589544B1/ko not_active Expired - Fee Related
- 2002-06-14 US US10/171,706 patent/US7148242B2/en not_active Expired - Fee Related
- 2002-06-14 PL PL02364476A patent/PL364476A1/xx not_active Application Discontinuation
- 2002-06-14 AT AT02754681T patent/ATE323081T1/de not_active IP Right Cessation
- 2002-06-14 NZ NZ529489A patent/NZ529489A/en unknown
- 2002-06-14 DK DK02754681T patent/DK1401828T3/da active
- 2002-06-14 RU RU2003137565/04A patent/RU2325386C2/ru not_active IP Right Cessation
- 2002-06-14 WO PCT/EP2002/006604 patent/WO2002102790A1/en not_active Ceased
- 2002-06-14 MX MXPA03011628A patent/MXPA03011628A/es active IP Right Grant
- 2002-06-14 IL IL15877002A patent/IL158770A0/xx unknown
- 2002-06-14 SI SI200230358T patent/SI1401828T1/sl unknown
- 2002-06-14 AU AU2002321062A patent/AU2002321062B2/en not_active Ceased
- 2002-06-14 PE PE2002000516A patent/PE20030100A1/es not_active Application Discontinuation
- 2002-06-14 CZ CZ20033388A patent/CZ20033388A3/cs unknown
- 2002-06-14 KR KR1020067002113A patent/KR20060014083A/ko not_active Ceased
- 2002-06-14 EP EP02754681A patent/EP1401828B1/en not_active Expired - Lifetime
- 2002-06-14 BR BR0210377-0A patent/BR0210377A/pt not_active IP Right Cessation
- 2002-06-14 HU HU0400208A patent/HUP0400208A3/hu unknown
- 2002-06-14 JP JP2003506263A patent/JP4361365B2/ja not_active Expired - Fee Related
- 2002-06-14 SK SK1524-2003A patent/SK15242003A3/sk not_active Application Discontinuation
-
2003
- 2003-10-28 ZA ZA200308379A patent/ZA200308379B/en unknown
- 2003-12-03 CO CO03106413A patent/CO5640131A2/es not_active Application Discontinuation
- 2003-12-12 NO NO20035571A patent/NO327420B1/no not_active IP Right Cessation
-
2006
- 2006-07-12 CY CY20061100965T patent/CY1105085T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20030100A1 (es) | Compuestos de n-formil-hidroxilamina | |
| ATE506354T1 (de) | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren | |
| PE20071176A1 (es) | Derivados diamina como inhibidores de leucotrieno a4 hidrolasa | |
| ATE253545T1 (de) | Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren | |
| YU72804A (sh) | N-aril-2-oksazolidinon-5-karboksamidi i njihovi derivati i njihova primena kao antibakterijskih sredstava | |
| NO20051411L (no) | Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk bruk derav samt intermediater til fremstilling derav | |
| SE0202465D0 (sv) | New compounds | |
| ATE360627T1 (de) | Pyrrolidindion-substituierte piperidin- phthalazone als pde4-inhibitoren | |
| EA200700185A1 (ru) | Производные хиназолиндиона в качестве ингибиторов parp | |
| PE20060215A1 (es) | 4-fenilamino-quinazolin-6-il-amidas | |
| TW200633991A (en) | Chemical compounds | |
| NO20031001L (no) | Polyarylkarboksamider nyttige som lipidsenkende midler | |
| TW200736221A (en) | Novel pharmaceutical salts and polymorphs of a Factor Xa inhibitor | |
| SE0100903D0 (sv) | Compounds | |
| DK1485359T3 (da) | Natriumkanalblokkere | |
| AR035111A1 (es) | Procedimiento para preparar un compuesto de pirimidinona | |
| BR0313969A (pt) | Inibidores de oxitocina | |
| SE0103710D0 (sv) | Compounds | |
| HRP20050803B1 (hr) | Novitetna kristalna modifikacija anhidrata boskalida | |
| PE20021013A1 (es) | Dihidropirimidinas-5-ciano sustituidos como agentes antiproliferativos | |
| ATE259376T1 (de) | Heterozyklische verbindungen, ihre zwischenprodukte und elastase-inhibitoren | |
| HRP20090128T3 (hr) | Tripeptid i tetrapeptid tioeteri | |
| ATE476431T1 (de) | Piperidin- und azetidinderivate als glyt1- inhibitoren | |
| BRPI0608400B8 (pt) | composto 2-(((4-((2,2-dimetil-1,3-dioxan-5-il)metóxi)-3,5-dimetilpiridin-2-il)metil)sulfinil)-1h-benzimidazol ou um sal de metal alcalino do mesmo | |
| PE20060184A1 (es) | Derivados de imidazoles como inhibidores de la sintesis del colesterol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |